Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06891638 · ClinicalTrials.gov registry record · NA
Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy
A NA study, sponsored by Kessler Foundation.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT06891638 is a NA study that has completed, run by Kessler Foundation. The registered enrollment target is 6 participants.
The verdict
NCT06891638, a NA study, has completed, sponsored by Kessler Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is designed for individuals with aphasia, a language disorder that affects many stroke survivors, making it difficult to read, speak, and understand language. Up to 70% of people with aphasia struggle with reading, which impacts their ability to communicate, work, and engage in daily life. The study aims to test a new approach to reading rehabilitation by combining Phono-Motor Treatment (PMT), a language therapy adapted to improve reading, with transcranial direct current stimulation (tDCS), a safe and painless brain stimulation technique. tDCS delivers a mild electrical current to the brain, which may enhance learning. This study will assess whether adding tDCS to PMT improves reading therapy outcomes.
Interventions
- DEVICE Schedule of tDCS administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2025-05-12 |
| Est. Completion | 2026-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06891638
The ClinicalTrials.gov registry entry for NCT06891638 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Schedule of tDCS administration is the first listed.
NCT06891638 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06891638 about?
NCT06891638 is a clinical study titled "Enhancing Reading Recovery in Aphasia With tDCS and Phonomotor Therapy". This study is designed for individuals with aphasia, a language disorder that affects many stroke survivors, making it difficult to read, speak, and understand language. Up to 70% of people with aphasia struggle with reading, which impacts their ability to communicate, work, and engage in daily life...
What is the current status of trial NCT06891638?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2025-05-12. Estimated completion is 2026-02-14.
What interventions are being tested in trial NCT06891638?
The interventions under investigation include: Schedule of tDCS administration (DEVICE).
Who is sponsoring clinical trial NCT06891638?
This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.